12 results about "Mongolian Medicines" patented technology

This invention relates to the field of medical data and discloses a method for real-time monitoring of the efficacy of traditional Chinese medicine, Mongolian medicine, and Western medicine based on biosensor technology. This method enables real-time monitoring of drug efficacy and personalized medication guidance. The process includes collecting real-time multimodal biosignals from the user's body surface or minimally invasive body fluid samples to obtain raw sensor signals and acquire sensor array output; extracting real-time pharmacokinetic characteristic signals based on a preset pharmacokinetic model and mapping them to efficacy assessment parameters according to drug type; comparing the efficacy assessment parameters with a preset safe and effective concentration range to generate real-time medication status indicators and dosage adjustment prompts. This invention designs quantitative assessment methods for different types of drugs, enabling real-time comparison to generate efficacy status codes and dosage adjustment suggestions. It comprehensively generates a medication guidance report and transmits it in real-time to the user or clinical monitoring end, allowing for immediate adjustment of the medication regimen and ensuring safe and effective medication.

This invention relates to the field of Mongolian medicine preparation technology, and discloses an Erdun-7 granule preparation and its preparation method, which is made from the following raw materials in parts by weight: 1 part of *Inula japonica* and 1.3-1.8 parts of *Rubus idaeus*, used to regulate qi, relieve exterior symptoms and reduce fever; 1.6-2.4 parts of *Sophora flavescens*, 0.7-1.3 parts of *Gardenia jasminoides*, and 0.7-1.3 parts of *Terminalia chebula*, used to enhance the heat-clearing, fire-purging, detoxifying and blood-cooling effects of *Inula japonica* and *Rubus idaeus*; 0.8-1.2 parts of *Uncaria rhynchophylla* and 0.8-1.2 parts of *Cicada slough*, used to calm the liver, extinguish wind, and stop spasms; and 0.7-1.3 parts of *Kaempferia galanga* and 0.7-1.3 parts of *Melia azedarach*. This Erdun-7 granule preparation and its preparation method target the anticonvulsant effect of the granules, prolonging the latency period and reducing the incidence and severity, which is significantly better than traditional preparations, demonstrating the synergistic effect of clearing heat and relieving exterior symptoms and extinguishing wind and stopping spasms.

The present application relates to the technical field of Mongolian medicine external preparation, in particular to a Mongolian medicine Sendeng-4 cream. The cream is prepared from Sendeng, Terminalia chebula, Gardenia jasminoides and Chinese Hopea as raw materials, and effective components are enriched by composite enzymolysis, supercritical CO2 two-phase extraction, gradient membrane separation and molecular imprinting purification. Then, the cream is prepared by adding composite penetration enhancer and plant source preservative after the pH-ROS response carrier targets drug loading and the temperature-sensitive composite matrix is microfluidic adapted. The present application solves the defects of traditional preparation, such as insufficient dissolution, poor stability and weak targeting, and has high cream purity, good skin permeability, excellent safety, stable long-term storage performance, and is suitable for skin inflammation, eczema, itching and other diseases. The cream has the advantages of traditional Mongolian medicine and modern preparation, and has a wide clinical application prospect.

This invention belongs to the technical field of Mongolian medicine composition, and discloses a Mongolian medicine composition for treating osteoporosis, its preparation and application. The composition, by weight, consists of 5-15 parts of ginseng, 10-20 parts of dragon bone, 8-18 parts of gypsum, 6-16 parts of pomegranate, 3-9 parts of cardamom, 4-12 parts of safflower, 2-8 parts of cinnamon, and 2-8 parts of long pepper. This Mongolian medicine composition integrates characteristic Mongolian medicines such as ginseng and gypsum, following the Mongolian medicine theory of "harmonizing cold and heat, and combining tonification and purgation." It can simultaneously act on three key pathological links: "inhibiting osteoclast activity," "promoting osteogenic differentiation," and "regulating the inflammatory microenvironment of bone tissue," achieving multi-target synergistic treatment. It not only effectively improves low bone mass but also significantly relieves bone pain, fundamentally intervening in bone metabolic imbalance and achieving a comprehensive therapeutic effect that addresses both the symptoms and the root cause.

This invention relates to the field of Mongolian medicine technology and discloses a Mongolian medicine composition for treating skin diseases caused by damp-heat and toxin accumulation. It aims to address the problem that existing technologies struggle to balance the efficacy of skin lesion treatment with the safety of systemic medication when treating patients with damp-heat and toxin accumulation skin diseases complicated by chronic diseases such as hypertension and asthma. This invention limits the specific weight ratio range between the heat-clearing and blood-cooling herbs and the harmonizing and strengthening herbs in the composition, and optimizes the synergistic relationship between the principal herbs and other adjuvant herbs. Under specific proportions, the composition maintains its basic effects of clearing heat and detoxifying, removing dampness and cooling blood, while enhancing its ability to clear damp-heat and toxins from the local skin. Furthermore, through the mutual restraint of the internal compatibility, it reduces potential interference with the patient's cardiovascular and respiratory systems. Therefore, this invention provides a new Mongolian medicine preparation that can safely and effectively treat skin diseases caused by damp-heat and toxin accumulation, especially suitable for patients with related chronic underlying diseases.

This invention discloses a Mongolian medicine compound for treating cold-type diarrhea and its preparation process. The compound consists of pomegranate, cinnamon, cardamom, long pepper, chebula, antidiarrheal seed, dried ginger, bright salt, black borneol, and white pepper in parts by weight. The process includes grouping the medicinal materials, independent low-temperature gradient processing of each herb, cell wall disruption by low-temperature gradient airflow at 5-5℃, gradient feeding and mixing under oxygen concentration ≤3% and 0-10℃ conditions, low-temperature condensation and collection of volatile oils from warm herbs at 10-5℃, low-pressure spray coupling after ethanol dilution, and microwave low-temperature sterilization. This invention significantly improves the dissolution and bioavailability of active ingredients by grouping and processing separately, low-temperature cell wall disruption, closed-loop recovery of volatile oils, and nitrogen-filled gradient mixing, while retaining volatile active ingredients and improving mixing uniformity and product stability. It has the advantages of rapid onset of action, definite curative effect, low recurrence rate, and controllable quality, and is suitable for the clinical treatment of cold-type diarrhea. It can be standardized for industrial production.

This invention relates to the field of medicine, and more particularly to a Mongolian medicine composition for treating rheumatoid arthritis and its preparation method. It comprises the following components in parts by weight: 10-40 parts of *Vernicia fordii*, 10-50 parts of *Sophora flavescens*, 10-50 parts of *Melia toosendan*, 10-30 parts of processed *Aconitum carmichaelii*, 10-30 parts of borneol, 10-20 parts of pearl, and 10-20 parts of dried ginger. This invention utilizes *Vernicia fordii* and *Qubadaganxila*, which have the effects of drying yellow fluid, clearing heat, reducing swelling, and relieving pain. *Melia toosendan* is the principal ingredient, *Sophora flavescens* and processed *Aconitum carmichaelii* are added as assistant ingredients, borneol and dried ginger are used as adjuvant ingredients, and pearl is used as the guiding ingredient. This formula has the combined effects of clearing heat, promoting digestion, improving blood circulation, relieving pain, and enhancing the body's immunity. Furthermore, the various medicinal materials complement each other and synergistically enhance the effect, thus exhibiting good efficacy for rheumatoid arthritis.

The present application relates to the technical field of medicine, in particular to the application of borneol in the preparation of a medicament for treating or preventing Alzheimer's disease. The present application finds that borneol has the effect of treating or preventing Alzheimer's disease; and borneol is used in combination with Mongolian medicine Zhenbao pill and / or synthetic drug 8e, compared with the use of Mongolian medicine Zhenbao pill or synthetic drug 8e alone, can significantly improve the effect of treating or preventing Alzheimer's disease, showing a synergistic effect. The present application provides a new treatment idea for the disease, and has good application prospect and industrial value.

The present application relates to the technical field of Mongolian medicine, and discloses a Mongolian medicine composition for treating irregular menstruation and hemostasis, which is based on the theory of treating liver blood together in Mongolian medicine, and solves the technical pain points of existing hemostatic Mongolian medicine by accurately limiting the proportion of core medicinal materials: the amount of mountain bitterleaf is 1.5 to 2.5 times that of safflower, the amount of bear gall powder is basically the same as or slightly higher than that of safflower, and the amount of ox gall powder is equal to or approximately equal to that of bear gall powder. This optimized proportion solves the problems of non-optimized compatibility ratio of classic Mongolian medicine prescriptions, weak synergistic effect of key medicinal materials, and single action dimension of modern purification scheme, which is difficult to harmonize blood heat and complex pathogenesis. The effects of various medicinal materials form a deep synergy, mountain bitterleaf clears liver heat, safflower and bear gall powder clear blood heat in the vein, and ox gall powder strengthens detoxification and anti-inflammatory effect. In animal models, the hemostatic effect is improved by more than 20% on average, the anti-inflammatory effect is outstanding, and a breakthrough is achieved from single-point hemostasis to multi-dimensional systemic regulation.

This invention relates to the field of Mongolian medicine medical device technology, and discloses a back heat therapy temperature monitoring device for Mongolian medicine tea and wine therapy, solving the problems mentioned in the background art. The device includes a heat therapy pad installed on the back area to be treated; a zoned variable density heating layer built into the heat therapy pad, divided into a central spine-corresponding zone and bilateral muscle-corresponding zones, with the heating element density in the central zone being lower than that in the bilateral zones; a distributed flexible temperature sensor array installed between the lower surface of the heat therapy pad and the skin, consisting of multiple sensor nodes arranged in a matrix and electrically connected to a microprocessor module; and adjustable fixing straps installed on both sides of the heat therapy pad, with pressure indicating elements on their inner sides. This invention compensates for temperature differences caused by the anatomical curvature of the back through zoned heating, achieves full-area temperature monitoring through a multi-point sensor array, and ensures stable fixation through pressure indicating straps, effectively improving the safety, comfort, and uniformity of therapeutic effects of tea and wine therapy.

The present invention relates to the technical field of Mongolian medicine, and discloses a Mongolian medicine named Renqing Wugete Busan for treating Heretic lung disease. This Mongolian medicine is composed of twenty-six medicinal materials including Gentiana algida Pall., Aquilaria sinensis (Lour.) Gilg, Choerospatha eriostachya (Wall.) Miq., Santalum album Linn., Myristica fragrans Houtt., Gypsum Fibrosum, Adenophora stricta Miq., Aucklandia lappa Decne., Terminalia chebula Retz., Melia toosendan Sieb. et Zucc., Gardenia jasminoides Ellis, Sophora flavescens Ait., Potentilla discolor Bunge, Dianthus superbus Linn., Eugenia caryophyllata Thunb., Glycyrrhiza glabra Linn., Vitis vinifera L., Cyperus rotundus L., Cinnamomum cassia Presl, Punica granatum L., Carthamus tinctorius L., Ilex purpurea Hassk., Alpinia oxyphylla Miq., Piper longum L., Neptunea arthritica cumingii, Bistorta officinalis Z. in specific weight part ratios. In the formula, Vitis vinifera L. and Myristica fragrans Houtt. are monarch drugs, Ilex purpurea Hassk., Carthamus tinctorius L., Gypsum Fibrosum, Glycyrrhiza glabra Linn., Adenophora stricta Miq., Cyperus rotundus L., Choerospatha eriostachya (Wall.) Miq., Santalum album Linn., Aquilaria sinensis (Lour.) Gilg are ministerial drugs, and the rest are adjuvant and guiding drugs. The total weight part ratio of the monarch drugs to the ministerial drugs is 1:3.0 - 3.4, and the total weight part ratio of the heat-clearing medicinal materials to the stomach-warming medicinal materials among the adjuvant and guiding drugs is 1:1.1 - 1.5. The present invention realizes the synchronous regulation of the disorder of Heretic and Badagan through scientific ratio, and takes into account the treatment of lung symptoms and gastrointestinal functions.